Skip to main content

Table 4 Comparison of the serum concentrations of UCP2 at before and after the intervention

From: The effect of omega3 fatty acid supplementation on PPARγ and UCP2 expressions, resting energy expenditure, and appetite in athletes

Variable

Omega-3 Group (n = 18)

Placebo Group (n = 18)

MD (95% CI), P

Ucp2 (ng/L)

 Before

15.6 (11.5, 27.9)

15.2 (11.8, 28.1)

0.37(− 0.47, 0.42), 0.91b

 After

22.1 (13.4, 29.4)

14.9 (10.4, 17.8)

7.17 (4.02, 12.8), 0.04 c

 MD (95% CI), pa

6.48 (3.08, 7.73), 0.01

−0.32 (0.12, 0.49), 0.01

 
  1. UCP2 uncoupling protein2; Mean (standard deviation), and mean difference (95% CI)
  2. a based on Wilcoxon signed-rank test
  3. b based on Mann–Whitney U test
  4. c based on Quantile regression adjusted for baseline values